Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-15,300
Closed -$13K 5593
2020
Q4
$13K Buy
15,300
+10,000
+189% +$330K ﹤0.01% 2971
2020
Q3
$26K Buy
5,300
+4,100
+342% +$174K ﹤0.01% 2247
2020
Q2
$3K Sell
1,200
-700
-37% -$35.8K ﹤0.01% 3559
2020
Q1
$12K Buy
+1,900
New +$86K ﹤0.01% 2608

Other funds holding ATEX

Cutler Group's ATEX Position: Q4 2021 in Review

Cutler Group sold out of Anterix (ATEX) in Q4 2021, closing a stake of 1,200 shares — an estimated $72K sold.

Cutler Group first reported a position in ATEX in Q4 2019 and held it in 7 quarters. The position peaked at $470K in Q3 2020. 108 funds tracked by Wall St. Rank hold ATEX as of Q4 2021.

  • Cutler Group reported no remaining Anterix position as of Q4 2021 after selling out during the quarter.
  • Cutler Group sold 1,200 Anterix shares in Q4 2021, an estimated $72K.
  • Cutler Group first reported a position in Anterix in Q4 2019 and held it in 7 quarters.
  • Cutler Group's Anterix position peaked at $470K in Q3 2020.
  • 108 funds tracked by Wall St. Rank held Anterix as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.